Product Name

  • Name

    4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide

  • EINECS 206-662-9
  • CAS No. 364-62-5
  • Article Data53
  • CAS DataBase
  • Density 1.162 g/cm3
  • Solubility
  • Melting Point 146-148 °C
  • Formula C14H22ClN3O2
  • Boiling Point 418.7 °C at 760 mmHg
  • Molecular Weight 299.801
  • Flash Point 207 °C
  • Transport Information
  • Appearance
  • Safety 36/37
  • Risk Codes 22-64
  • Molecular Structure Molecular Structure of 364-62-5 (4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide)
  • Hazard Symbols Xn
  • Synonyms o-Anisamide,4-amino-5-chloro-N-[2-(diethylamino)ethyl]- (7CI,8CI);2-Methoxy-4-amino-5-chloro-N,N-dimethylaminoethylbenzamide;2-Methoxy-5-chloroprocainamide;N-[2-(Diethylamino)ethyl]-4-amino-5-chloro-2-methoxybenzamide;Plasil;Primperan;Regla;4-Amino-5-chloro-2-methoxy-N-(b-diethylaminoethyl)benzamide;4-Amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide;4-Amino-5-chloro-N-[2-(diethylamino)ethyl]-o-anisamide;5-Chloro-2-methoxyprocainamide;Clopromate;DEL 1267;Draclamid;Eucil;Gastrese;Gastro-Timelets;Gastromax;Gastrosil;Gastrotem;MCP-ratiopharm;Macperan;Maxeran;Meclopran;Metamide;Metoclol;Metramid;Moriperan;N-(2-Diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide;N-(Diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide;
  • PSA 67.59000
  • LogP 2.97450

Synthetic route

4-amino-5-chloro-2-methoxybenzoic acid
7206-70-4

4-amino-5-chloro-2-methoxybenzoic acid

N,N-diethylethylenediamine
100-36-7

N,N-diethylethylenediamine

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
With borane-ammonia complex In 5,5-dimethyl-1,3-cyclohexadiene for 6h; Reflux;88%
reglan
7232-21-5

reglan

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
With sodium hydrogencarbonate In methanol; dichloromethane65%
methyl 2-methoxy 4-acetamido 5-chloro benzoate
4093-31-6

methyl 2-methoxy 4-acetamido 5-chloro benzoate

N,N-diethylethylenediamine
100-36-7

N,N-diethylethylenediamine

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
With sodium hydroxide; acetic acid 1.) 90-95 deg C, 4 h, 2.) water, heating; Yield given. Multistep reaction;
C11H12ClNO5
150007-96-8

C11H12ClNO5

N,N-diethylethylenediamine
100-36-7

N,N-diethylethylenediamine

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
In tetrahydrofuran for 3h; Ambient temperature; Yield given;
4-amino-5-chloro-2-methoxybenzoic acid
7206-70-4

4-amino-5-chloro-2-methoxybenzoic acid

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine / tetrahydrofuran / 1 h / 0 °C
2: tetrahydrofuran / 3 h / Ambient temperature
View Scheme
Methyl 4-amino-2-methoxybenzoate
27492-84-8

Methyl 4-amino-2-methoxybenzoate

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: H2O / 1.) room temp., 30 min., 2.) 60-70 deg C, 1 h
2: aq. sodium hypochlorite / 1 h
3: 1.) glacial acetic acid, 2.) NaOH / 1.) 90-95 deg C, 4 h, 2.) water, heating
View Scheme
methyl 4-(acetylamino)-o-anisate
4093-29-2

methyl 4-(acetylamino)-o-anisate

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq. sodium hypochlorite / 1 h
2: 1.) glacial acetic acid, 2.) NaOH / 1.) 90-95 deg C, 4 h, 2.) water, heating
View Scheme
4-amino-5-chloro-2-methoxybenzoic acid
7206-70-4

4-amino-5-chloro-2-methoxybenzoic acid

N,N-diethylethylenediamine
100-36-7

N,N-diethylethylenediamine

1-methanesulfonyloxy-1,2,3-benzotriazole
54769-22-1

1-methanesulfonyloxy-1,2,3-benzotriazole

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
With sodium hydroxide; triethylamine In chloroform; water
C17H27ClN4O2
89881-28-7

C17H27ClN4O2

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
Stage #1: C17H27ClN4O2 With ethylenediamine In ethanol for 10h; Reflux;
Stage #2: With water
2.32 g
carbon monoxide
201230-82-2

carbon monoxide

2-chloro-4-iodo-5-methoxyaniline
1285695-15-9

2-chloro-4-iodo-5-methoxyaniline

N,N-diethylethylenediamine
100-36-7

N,N-diethylethylenediamine

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
With triethylamine; triphenylphosphine; bis(dibenzylideneacetone)-palladium(0) In 1,4-dioxane at 80℃; Inert atmosphere; Sealed chamber;63.2 mg
2-chloro-5-methoxyaniline
2401-24-3

2-chloro-5-methoxyaniline

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: ethyl acetate
2: triethylamine; triphenylphosphine; bis(dibenzylideneacetone)-palladium(0) / 1,4-dioxane / 80 °C / Inert atmosphere; Sealed chamber
View Scheme
metoclopramide
364-62-5

metoclopramide

4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-hydroxybenzamide
38339-95-6

4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-hydroxybenzamide

Conditions
ConditionsYield
With sodium hydride; ethanethiol In N,N-dimethyl-formamide at 100 - 105℃; for 1.5h;98%
NH4(1+)*Cr(3+)*4NSC(1-)*2NH2C6H5 = NH4[Cr(NCS)4(NH2C6H5)2]

NH4(1+)*Cr(3+)*4NSC(1-)*2NH2C6H5 = NH4[Cr(NCS)4(NH2C6H5)2]

metoclopramide
364-62-5

metoclopramide

4CNS(1-)*Cr(3+)*2C6H7N*C14H22ClN3O2*H(1+)

4CNS(1-)*Cr(3+)*2C6H7N*C14H22ClN3O2*H(1+)

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water97%
metoclopramide
364-62-5

metoclopramide

Reinecke's salt

Reinecke's salt

4CNS(1-)*2H3N*Cr(3+)*C14H22ClN3O2*H(1+)

4CNS(1-)*2H3N*Cr(3+)*C14H22ClN3O2*H(1+)

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water96%
NH4(1+)*Cr(3+)*4NSC(1-)*2NH2CH2C6H5 = NH4[Cr(NCS)4(NH2CH2C6H5)2]

NH4(1+)*Cr(3+)*4NSC(1-)*2NH2CH2C6H5 = NH4[Cr(NCS)4(NH2CH2C6H5)2]

metoclopramide
364-62-5

metoclopramide

4CNS(1-)*Cr(3+)*2C7H9N*H(1+)*C14H22ClN3O2

4CNS(1-)*Cr(3+)*2C7H9N*H(1+)*C14H22ClN3O2

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water95%
metoclopramide
364-62-5

metoclopramide

2C6H12N4*4CNS(1-)*Cr(3+)*H4N(1+)

2C6H12N4*4CNS(1-)*Cr(3+)*H4N(1+)

2C6H12N4*4CNS(1-)*Cr(3+)*H(1+)*C14H22ClN3O2

2C6H12N4*4CNS(1-)*Cr(3+)*H(1+)*C14H22ClN3O2

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water93%
metoclopramide
364-62-5

metoclopramide

4CNS(1-)*Cr(3+)*H4N(1+)*2C6H5N3

4CNS(1-)*Cr(3+)*H4N(1+)*2C6H5N3

4CNS(1-)*Cr(3+)*H(1+)*2C6H5N3*C14H22ClN3O2

4CNS(1-)*Cr(3+)*H(1+)*2C6H5N3*C14H22ClN3O2

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water92%
metoclopramide
364-62-5

metoclopramide

4CNS(1-)*Cr(3+)*H4N(1+)*2C3H4N2

4CNS(1-)*Cr(3+)*H4N(1+)*2C3H4N2

4CNS(1-)*Cr(3+)*2C3H4N2*C14H22ClN3O2*H(1+)

4CNS(1-)*Cr(3+)*2C3H4N2*C14H22ClN3O2*H(1+)

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water91%
metoclopramide
364-62-5

metoclopramide

trifluoroacetic anhydride
407-25-0

trifluoroacetic anhydride

5-Chloro-N-(2-diethylamino-ethyl)-2-methoxy-4-(2,2,2-trifluoro-acetylamino)-benzamide
820965-31-9

5-Chloro-N-(2-diethylamino-ethyl)-2-methoxy-4-(2,2,2-trifluoro-acetylamino)-benzamide

Conditions
ConditionsYield
With triethylamine In chloroform86%
metoclopramide
364-62-5

metoclopramide

chloranil
118-75-2

chloranil

C14H22ClN3O2*C6Cl4O2
1569295-24-4

C14H22ClN3O2*C6Cl4O2

Conditions
ConditionsYield
In methanol at 20℃; for 0.25h; Thermodynamic data;82%
metoclopramide
364-62-5

metoclopramide

4-chlorophenyloxyacetyl chloride
4122-68-3

4-chlorophenyloxyacetyl chloride

cloxacepride
65569-29-1

cloxacepride

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;80.7%
metoclopramide
364-62-5

metoclopramide

2-cyclopentyl-2-hydroxy-2-phenylacetic acid
427-49-6

2-cyclopentyl-2-hydroxy-2-phenylacetic acid

2-chloro-4-{[2-(diethylamino)ethyl]carbamoyl}-5-methoxyanilinium-2-cyclopentyl-2-hydroxy-2-phenylacetate

2-chloro-4-{[2-(diethylamino)ethyl]carbamoyl}-5-methoxyanilinium-2-cyclopentyl-2-hydroxy-2-phenylacetate

Conditions
ConditionsYield
In acetone for 6h; Inert atmosphere; Reflux;80%
metoclopramide
364-62-5

metoclopramide

2-(4-fluorophenoxy)acetyl chloride
405-78-7

2-(4-fluorophenoxy)acetyl chloride

5-Chloro-N-(2-diethylamino-ethyl)-4-[2-(4-fluoro-phenoxy)-acetylamino]-2-methoxy-benzamide
85630-52-0

5-Chloro-N-(2-diethylamino-ethyl)-4-[2-(4-fluoro-phenoxy)-acetylamino]-2-methoxy-benzamide

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;78.3%
metoclopramide
364-62-5

metoclopramide

metoclopramide N-oxide
171367-22-9

metoclopramide N-oxide

Conditions
ConditionsYield
With dihydrogen peroxide Ambient temperature;77%
With 3-chloro-benzenecarboperoxoic acid In dichloromethane for 0.333333h; Ambient temperature;
Multi-step reaction with 3 steps
1: 86 percent / Et3N / CHCl3
2: 100 percent / m-chloroperbenzoic acid / CHCl3 / Ambient temperature
3: 100 percent / aq. Na2CO3 / methanol / Ambient temperature
View Scheme
metoclopramide
364-62-5

metoclopramide

urea
57-13-6

urea

4-Amino-5-cyano-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
65016-46-8

4-Amino-5-cyano-N-(2-diethylamino-ethyl)-2-methoxy-benzamide

Conditions
ConditionsYield
With nickel(II) acetylacetonate; potassium fluoride; phenylsilane; zinc; bis(2-diphenylphosphinoethyl)phenylphosphine In 1-methyl-pyrrolidin-2-one at 120℃; for 20h;76%
metoclopramide
364-62-5

metoclopramide

7,7',8,8'-tetracyanoquinodimethane
1518-16-7

7,7',8,8'-tetracyanoquinodimethane

C14H22ClN3O2*C12H4N4
1569257-76-6

C14H22ClN3O2*C12H4N4

Conditions
ConditionsYield
In methanol at 20℃; for 0.25h; Thermodynamic data;75%
metoclopramide
364-62-5

metoclopramide

2,3-dicyano-5,6-dichloro-p-benzoquinone
84-58-2

2,3-dicyano-5,6-dichloro-p-benzoquinone

C14H22ClN3O2*C8Cl2N2O2
1569257-75-5

C14H22ClN3O2*C8Cl2N2O2

Conditions
ConditionsYield
In methanol at 20℃; for 0.25h; Thermodynamic data;73%
metoclopramide
364-62-5

metoclopramide

(2-chloro-phenoxy)-acetyl chloride
20143-41-3

(2-chloro-phenoxy)-acetyl chloride

5-Chloro-4-[2-(2-chloro-phenoxy)-acetylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
65569-40-6

5-Chloro-4-[2-(2-chloro-phenoxy)-acetylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;72.4%
metoclopramide
364-62-5

metoclopramide

4-nitro-benzoic acid
62-23-7

4-nitro-benzoic acid

C14H22ClN3O2*C7H5NO4
1569257-78-8

C14H22ClN3O2*C7H5NO4

Conditions
ConditionsYield
In methanol at 20℃; for 0.25h; Thermodynamic data;71%
metoclopramide
364-62-5

metoclopramide

C14H21(2)HClN3O2

C14H21(2)HClN3O2

Conditions
ConditionsYield
With rhodium(III) chloride; water-d2 In N,N-dimethyl-formamide at 108℃;70%
metoclopramide
364-62-5

metoclopramide

2-(2,4-dichlorophenoxy)acetyl chloride
774-74-3

2-(2,4-dichlorophenoxy)acetyl chloride

5-Chloro-4-[2-(2,4-dichloro-phenoxy)-acetylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
85630-56-4

5-Chloro-4-[2-(2,4-dichloro-phenoxy)-acetylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;69.6%
metoclopramide
364-62-5

metoclopramide

2-(4-Chlorophenoxy)propionic acid chloride
4878-20-0

2-(4-Chlorophenoxy)propionic acid chloride

5-Chloro-4-[2-(4-chloro-phenoxy)-propionylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
65569-34-8

5-Chloro-4-[2-(4-chloro-phenoxy)-propionylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;68.3%
metoclopramide
364-62-5

metoclopramide

2,4,6-Trinitrophenol
88-89-1

2,4,6-Trinitrophenol

C14H22ClN3O2*C6H3N3O7
1569257-74-4

C14H22ClN3O2*C6H3N3O7

Conditions
ConditionsYield
In methanol at 20℃; for 0.25h; Thermodynamic data;66%
metoclopramide
364-62-5

metoclopramide

1,2-bis(4-formylphenoxy)ethane
34074-28-7

1,2-bis(4-formylphenoxy)ethane

C44H54Cl2N6O6

C44H54Cl2N6O6

Conditions
ConditionsYield
With acetic acid In ethanol Reflux;65%
meta-dinitrobenzene
99-65-0

meta-dinitrobenzene

metoclopramide
364-62-5

metoclopramide

C14H22ClN3O2*C6H4N2O4
1569257-77-7

C14H22ClN3O2*C6H4N2O4

Conditions
ConditionsYield
In methanol at 20℃; for 0.25h; Thermodynamic data;62%
metoclopramide
364-62-5

metoclopramide

p-methoxyphenoxyacetyl chloride
42082-29-1

p-methoxyphenoxyacetyl chloride

5-Chloro-N-(2-diethylamino-ethyl)-2-methoxy-4-[2-(4-methoxy-phenoxy)-acetylamino]-benzamide
85630-60-0

5-Chloro-N-(2-diethylamino-ethyl)-2-methoxy-4-[2-(4-methoxy-phenoxy)-acetylamino]-benzamide

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;60%
metoclopramide
364-62-5

metoclopramide

(2,3-dichlorophenoxy)acetyl chloride
85630-84-8

(2,3-dichlorophenoxy)acetyl chloride

5-Chloro-4-[2-(2,3-dichloro-phenoxy)-acetylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
85630-58-6

5-Chloro-4-[2-(2,3-dichloro-phenoxy)-acetylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;59.7%
metoclopramide
364-62-5

metoclopramide

2-(4-iodophenoxy)acetyl chloride
20143-44-6

2-(4-iodophenoxy)acetyl chloride

5-Chloro-N-(2-diethylamino-ethyl)-4-[2-(4-iodo-phenoxy)-acetylamino]-2-methoxy-benzamide
65569-50-8

5-Chloro-N-(2-diethylamino-ethyl)-4-[2-(4-iodo-phenoxy)-acetylamino]-2-methoxy-benzamide

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;59.2%

Metoclopramide Specification

The CAS registry number of Metoclopramide is 364-62-5. With the EINECS registry number 206-662-9, its systematic name is 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide. In addition, the molecular formula is C14H22ClN3O2. What's more, it should be stored in sealed container, and put in a cool and dry place.

Physical properties about this chemical are: (1)ACD/LogP: 2.22; (2)ACD/LogD (pH 5.5): -0.85; (3)ACD/LogD (pH 7.4): 0.04; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 1; (7)ACD/KOC (pH 7.4): 2.54; (8)#H bond acceptors: 5; (9)#H bond donors: 3; (10)#Freely Rotating Bonds: 8; (11)Polar Surface Area: 36.02 Å2; (12)Index of Refraction: 1.553; (13)Molar Refractivity: 82.57 cm3; (14)Molar Volume: 257.8 cm3; (15)Polarizability: 32.73 ×10-24cm3; (16)Surface Tension: 43.8 dyne/cm; (17)Density: 1.162 g/cm3; (18)Flash Point: 207 °C; (19)Enthalpy of Vaporization: 67.23 kJ/mol; (20)Boiling Point: 418.7 °C at 760 mmHg; (21)Vapour Pressure: 3.22E-07 mmHg at 25°C.

Preparation of Metoclopramide: It can start with the esterification, acylation and methylation of p-aminosalicylic acid, and gives methyl p-acetamido-methoxybenzoate. The methyl p-acetamido-methoxybenzoate can go through chlorination, amination and hydrolysis to give the desired product.

Uses of Metoclopramide: it can be used to get metoclopramide N-oxide. This reaction will need reagent m-chloroperbenzoic acid and solvent CH2Cl2. The reaction time is 20 minutes with ambient temperature.

Metoclopramide can be used to get metoclopramide N-oxide

You can still convert the following datas into molecular structure:
(1)SMILES: Clc1cc(c(OC)cc1N)C(=O)NCCN(CC)CC
(2)Std. InChI: InChI=1S/C14H22ClN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19)
(3)Std. InChIKey: TTWJBBZEZQICBI-UHFFFAOYSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
child TDLo intravenous 2mg/kg/1D-C (2mg/kg) BEHAVIORAL: EXCITEMENT Journal of Pediatrics. Vol. 104, Pg. 138, 1984.
child TDLo oral 900ug/kg (0.9mg/kg) SENSE ORGANS AND SPECIAL SENSES: DIPLOPIA: EYE

BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
Archives of Disease in Childhood. Vol. 55, Pg. 310, 1980.
infant TDLo oral 3mg/kg/9H-I (3mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: ATAXIA
Pediatric Emergency Care. Vol. 14, Pg. 39, 1998.
man TDLo intravenous 14ug/kg (0.014mg/kg) VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION Annals of Internal Medicine. Vol. 104, Pg. 125, 1986.
man TDLo oral 111mg/kg/37W- (111mg/kg) PERIPHERAL NERVE AND SENSATION: FASCICULATIONS Japanese Journal of Medicine. Vol. 23, Pg. 152, 1984.
man TDLo oral 632mg/kg/59D- (632mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: TOXIC PSYCHOSIS

BEHAVIORAL: EXCITEMENT
Journal of Clinical Psychiatry. Vol. 48, Pg. 38, 1987.
mouse LD50 intraperitoneal 96mg/kg (96mg/kg)   Drugs in Japan Vol. 6, Pg. 838, 1982.
mouse LD50 intravenous 33mg/kg (33mg/kg)   Drugs in Japan Vol. 6, Pg. 838, 1982.
mouse LD50 oral 270mg/kg (270mg/kg)   Drugs in Japan Vol. 6, Pg. 838, 1982.
mouse LD50 subcutaneous 190mg/kg (190mg/kg)   Drugs in Japan Vol. 6, Pg. 838, 1982.
rabbit LD50 intravenous 30mg/kg (30mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, 1967.
rat LD50 intraperitoneal 114mg/kg (114mg/kg)   Drugs in Japan Vol. 6, Pg. 838, 1982.
rat LD50 intravenous 50mg/kg (50mg/kg)   Bollettino Chimico Farmaceutico. Vol. 115, Pg. 649, 1976.
rat LD50 oral 750mg/kg (750mg/kg)   Drugs in Japan Vol. 6, Pg. 838, 1982.
rat LD50 subcutaneous 340mg/kg (340mg/kg)   Drugs in Japan Vol. 6, Pg. 838, 1982.
women TDLo intravenous 2400ug/kg (2.4mg/kg) VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION New England Journal of Medicine. Vol. 307, Pg. 1346, 1982.
women TDLo oral 3600ug/kg/6D- (3.6mg/kg) BEHAVIORAL: TREMOR

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
Annals of Internal Medicine. Vol. 97, Pg. 621, 1982.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View